Testing Status of AZT + Isoniazid (AIDS Initiative) M930018
CASRN: AZTISONIAZID
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 54-85-3 - Isoniazid
Short-Term Toxicity
- 13 weeks (Gavage)
(C93001)
Completed
- Mice: B6C3F1
- Dose: AZT: 100, 200, or 400 mg/kg/day; isoniazid: 50, 100, or 150 mg/kg/day.
Organ Systems Toxicity
- 1 to 31 Repro/Dev Gen Tox (28-Day) (Gavage)
(RACB93150)
Completed
- NIH Number: 99-3941
Citation: NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-dioxythymidine (AZT) and Isoniazid Combinations (CASRNs 30516-87-1 and 54-85-3) Administered by Gavage to Swiss (CD-1®) Mice - Male and Female Mice: Swiss CD-1
- Dose: N/A; N/A; N/A; N/A.
- NIH Number: 99-3941